Back to Journals » Psoriasis: Targets and Therapy » Volume 11 » default

Psoriasis: Targets and Therapy


Archive: Volume 11, 2021

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios

Rajagopalan M, Dogra S, Saraswat A, Varma S, Banodkar P

Psoriasis: Targets and Therapy 2021, 11:109-122

Published Date: 14 August 2021

Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics

Ben Abdallah H, Johansen C, Iversen L

Psoriasis: Targets and Therapy 2021, 11:83-97

Published Date: 29 June 2021

Updates on the Treatment of Erythrodermic Psoriasis

Lo Y, Tsai TF

Psoriasis: Targets and Therapy 2021, 11:59-73

Published Date: 9 June 2021

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population

Cassia FF, Cardoso JF, Porto LC, Ramos-e-Silva M, Carneiro S

Psoriasis: Targets and Therapy 2021, 11:41-51

Published Date: 10 May 2021

Frequency of Health Care Resource Utilization and Direct Medical Costs Associated with Psoriatic Arthritis in a Rheumatic Care Center in Colombia

Santos-Moreno P, Gómez-De la Rosa F, Parra-Padilla D, Alvis-Zakzuk NJ, Alvis-Zakzuk NR, Carrasquilla-Sotomayor M, Valencia O, Alvis-Guzmán N

Psoriasis: Targets and Therapy 2021, 11:31-39

Published Date: 18 March 2021

Phosphodiesterase-4 Inhibition in Psoriasis

Milakovic M, Gooderham MJ

Psoriasis: Targets and Therapy 2021, 11:21-29

Published Date: 17 March 2021

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic

Haulrig MB, Zachariae C, Skov L

Psoriasis: Targets and Therapy 2021, 11:1-20

Published Date: 11 February 2021